JP Morgan Healthcare conference: impact on the biotech sector and the XBI
PremiumMarket Overview·Jan 11, 2025·2 min read
Market OverviewPremium
JP Morgan Healthcare conference: impact on the biotech sector and the XBI
Jan 11, 2025 · 2 min
RGNX: analyst ratings and target prices
PremiumAnalysts·RGNX·Sep 9, 2026·1 min read
AnalystsPremium
RGNX
RGNX: analyst ratings and target prices
Sep 9, 2026 · 1 min
Almost a million dollars – just two days after joining the board
PremiumInsiders·RGNX·Sep 8, 2026·5 min read
InsidersPremiumRGNX
Almost a million dollars – just two days after joining the board
Sep 8, 2026 · 5 min
We identified an unimaginable 350% upside in the biotechnology sector
PremiumAnalysts·RGNX·Mar 16, 2026·1 min read
AnalystsPremiumRGNX
We identified an unimaginable 350% upside in the biotechnology sector
Mar 16, 2026 · 1 min
Wave of acquisitions in biotech: JNJ and GSK in action
PremiumBreaking·XBI·Jan 13, 2025·1 min read
BreakingPremium
XBI
Wave of acquisitions in biotech: JNJ and GSK in action
Jan 13, 2025 · 1 min